3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
19
Neoplasms
12
Colorectal Neoplasms
5
Pain, Postoperative
4
Fatigue
4
Thyroid Neoplasms
3
Stomatitis
3
Pain
3
Malnutrition
3
Liver Neoplasms
3
Depression
3
Carcinoma, Hepatocellular
3
Anxiety Disorders
3
Stomach Neoplasms
2
Sleep Initiation and Maintenance Disorders
2
Polycystic Ovary Syndrome
2
Parasomnias
2
Motor Activity
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Breast Cancer Female
2
Agnosia
2
Weight Loss
1
Vomiting
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Incontinence
1
Unilateral U/S PVB
1
Ulcer
1
Interventions
pimodivir
1
Sunitinib
1
Rosuvastatin Calcium
1
Olive Oil
1
Midazolam
1
Interviews as Topic
1
Cyclosporine
1
Control Groups
1
Blood Specimen Collection
1
Adalimumab
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Healthy
×
Control Groups
×
Clear all
NCT01408459
2025-05-16
DAPH
University of Illinois at Chicago
Phase NA
Completed
37 enrolled
9 charts